ArticleJournal of diabetes and metabolic disorders2025
The association of plasma level of phenylalanine with inflammatory markers, insulin resistance, and atherosclerotic indexes in patients with phenylketonuria.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparative Analysis of Dietary Patterns in Children With Phenylketonuria Phenotypes and Controls: Implications for Nutritional Status.Journal of inherited metabolic disease · 2026Article
- The First 1000 Days of PKU: A Narrative Review of Maternal PKU and Early Life Management After Positive Newborn Screening.Nutrients · 2026Review
- The Association Between Dietary Intake of Aromatic Amino Acids and Metabolic Syndrome.Journal of nutrition and metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Patients with phenylketonuria (PKU) are at increasing risk of metabolic disorders and atherosclerosis. This case-control study aimed to compare the values of atherosclerosis risk factors, including insulin resistance (IR), dyslipidemia, mean of platelet volume (MPV), and systemic inflammation in adult PKU patients. Methods: Fifty patients with PKU were categorized into two groups: well-controlled (WC) (plasma Phe < 600 µmol/L) and poorly controlled (PC) (Phe > 600 µmol/L). Twenty-five age -, gender -, and BMI-matched healthy individuals were enrolled as the control group. Serum insulin, fasting blood sugar (FBS), and lipids were measured. The systemic inflammatory index (SII) and systemic inflammatory response index (SIRI) were calculated using the counts of neutrophils, lymphocytes, monocytes, and platelets. Results: Both PKU groups had lower serum cholesterol, low-density lipoprotein, and high-density lipoprotein than the healthy subjects (p < 0.001). No significant difference was observed in IR between the PKU patients and the control group. MPV was significantly higher in the patients with PKU compared to the healthy controls. The levels of SII and SIRI were substantially lower in the WC group compared to the healthy control group and the PC group. Conclusions: All in all, a higher level of dyslipidemia and MPV were observed in patients with PKU compared to healthy individuals. SII and SIRI were significantly lowered in the WC group compared to the PC group and healthy individuals, suggesting the role of adherence to a restricted diet in reducing the risk of systemic inflammation in patients with PKU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.